# Genentech, Inc. – FDA 483, Sep 27, 2011

Source: https://www.keypedia.com/records/483/genentech-inc/18f90c1b-4f69-4c48-99f7-a22fc019324c

> FDA 483 for Genentech, Inc. on September 27, 2011. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Genentech, Inc.
- Inspection Date: 2011-09-27
- Office Name: San Francisco District Office
- Summary: This FDA Form 483 was issued to Genentech Inc., a manufacturer located at 1 DNA Way, South San Francisco, CA, following an inspection from September 2 to September 27, 2011. The report was addressed to Andrea J. Goddard, Senior Director and SSF Site Quality Head.

The inspection revealed four observations:

1.  **Inadequate Investigation Records (Repeat Observation):** Written records of investigations into discrepancies and batch failures lacked conclusions and follow-up.
    *   Deviation Report #506273 (disintegrating gaskets on vial washer) failed to include comparison of particulates from culled Avastin vials with the gasket material to rule out contamination of a quarantined lot.
    *   Deviation Report #464179 (capper power outage) failed to describe actions taken for a capper oil leak and disposition of in-process vials, lacking assurance of repair before resuming manufacturing or proper discard of vials.

2.  **Inappropriate Equipment Design:** Equipment used in manufacturing was not of appropriate design for its intended use.
    *   No data assures Avastin vial conveyance and capping occurs in a "Controlled Primary HEPA filtered Area" as described in BLA #125085. A gap in the capping area's HEPA filter coverage appeared to allow influx of Class [redacted] air.
    *   Lack of adequate documented evidence to

## Related Documents

- [483 - 2024-03-12](https://www.keypedia.com/records/483/genentech-inc/7887b305-0de6-472c-b596-8cbd94e8d300) — date: March 12, 2024
- [483 - 2023-08-11](https://www.keypedia.com/records/483/genentech-inc/ce85e9f0-3331-495a-b1b4-a7e2df5fa79b) — date: August 11, 2023
- [483 - 2023-01-31](https://www.keypedia.com/records/483/genentech-inc/e020acbc-f66e-4314-a8bc-c156ef8c9a94) — date: January 31, 2023
- [EIR - 2022-10-07](https://www.keypedia.com/records/eir/genentech-inc/c790563c-45ba-439c-8c24-6cd1f80fcf3f) — date: October 7, 2022
- [483 - 2022-05-26](https://www.keypedia.com/records/483/genentech-inc/3b630c1e-0dc5-44a8-a456-256f25c6a163) — date: May 26, 2022

## Related Officers

- [President](https://www.keypedia.com/people/peter-e-baker/c32eb848-de28-4725-80c9-ef8548d445bf)
- [CEO](https://www.keypedia.com/people/jeffrey-k-matson/876c9865-5249-4383-a0fc-a60b86b88808)
- [Menzy R. Lau](https://www.keypedia.com/people/menzy-r-lau/1abf5e26-1c24-4c94-835f-98462626d2ae)
- [Investigator](https://www.keypedia.com/people/min-shan-mabel-liu/d6e331ea-7d16-4635-bd74-7d753f16075d)
- [Founder](https://www.keypedia.com/people/henry-k-lau/5c771e20-2202-4a20-8d95-33060ca28b7c)

Company: https://www.keypedia.com/companies/genentech-inc/709aa262-e8df-42fa-bec6-02673e7f52ec

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df